In order to best ensure equal treatment, successful stage 1 applicants do not receive the evaluation summary reports (ESRs) for their proposals, but this generalised feedback with information and tips for preparing the full proposal.
HLTH-2022-STAYHLTH-01-two-stage
Information & tips
Main suggestions to stage 2 applicants:
- The proposal should address all the individual sub-criteria under in the appropriate section of the proposal. The methodology, inter-disciplinarily, current state of the art and – where relevant – use of AI should be clearly described.
- Where relevant, aspects such as robustness of co-design, stigmatisation, pilot data and other feasibility data should be addressed in a satisfactory level of detail.
- Overall impacts and how they can be reached should be clearly described.
- Where relevant, prevention of obesity evidence, primary prevention and secondary prevention should be considered - actions for people who are at greater risk than the average of becoming obese or timely prevention or how to implement the existing evidence.
- If the proposal contains clinical studies, please read carefully the definition and guidance on the template ‘Information on clinical studies' published on the call page in the Participant Portal (https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-clinical-studies_he_en.docx) and remember to upload the template filled in when submitting your proposal.
HORIZON-HLTH-2022-DISEASE-06-two-stage
Information & tips
Main suggestions to stage 2 applicants:
- The proposal should address all the individual sub-criteria under in the appropriate section of the proposal. The methodology, current state of the art and – where relevant – use of AI should be clearly described.
- Where relevant, preliminary data (even if unpublished) should be presented.
- Where relevant, detailed information on epitopes should be given.
- If the proposal contains clinical studies, please read carefully the definition and guidance on the template ‘Information on clinical studies' published on the call page in the Participant Portal (https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-clinical-studies_he_en.docx) and remember to upload the template filled in when submitting your proposal
HORIZON-HLTH-2022-TOOL-12-two-stage
Information & tips
Main suggestions to stage 2 applicants:
- The proposal should address all the individual sub-criteria under in the appropriate section of the proposal. The methodology, current state of the art and – where relevant – use of AI should be clearly described.
- The quality of data and standards should be emphasised.
- If the proposal contains clinical studies, please read carefully the definition and guidance on the template ‘Information on clinical studies' published on the call page in the Participant Portal (https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-clinical-studies_he_en.docx) and remember to upload the template filled in when submitting your proposal.
In stage 2 off all above mentioned proposals, there will be a chance to address or clarify these issues. Please bear in mind that the full proposal will now be evaluated more in-depth and possibly by a new group of outside experts.
Please make sure that the full proposal is consistent with your short outline proposal. It may not differ substantially. The project must remain the same.
Source: Funding and Tender Portal
